Seroatlas · Human Serome Atlas

HPDL

4-hydroxyphenylpyruvate dioxygenase-like protein

Also known as: 4-HPPD-L, GLOXD1, HPDL_HUMAN, MGC15668

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96IR7
Gene
HPDL
Ensembl
ENSG00000186603
Chromosome
1
Canonical length
371 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Mitochondria

OverviewNCBI Gene

The protein encoded by this intronless gene localizes to mitochondria, where it may function as 4-hydroxyphenylpyruvate dioxygenase. Clinical studies have identified several bi-allelic variants in this gene that lower the level of the encoded protein and lead to a clinically variable form of pediatric-onset spastic movement disorder. [provided by RefSeq, Aug 2020]

Canonical amino-acid sequenceUniProt

371 residues, UniProt reviewed canonical sequence.

>Q96IR7|HPDL
     1  MAAPALRLCH IAFHVPAGQP LARNLQRLFG FQPLASREVD GWRQLALRSG DAVFLVNEGA
    61  GSGEPLYGLD PRHAVPSATN LCFDVADAGA ATRELAALGC SVPVPPVRVR DAQGAATYAV
   121  VSSPAGILSL TLLERAGYRG PFLPGFRPVS SAPGPGWVSR VDHLTLACTP GSSPTLLRWF
   181  HDCLGFCHLP LSPGEDPELG LEMTAGFGLG GLRLTALQAQ PGSIVPTLVL AESLPGATTR
   241  QDQVEQFLAR HKGPGLQHVG LYTPNIVEAT EGVATAGGQF LAPPGAYYQQ PGKERQIRAA
   301  GHEPHLLARQ GILLDGDKGK FLLQVFTKSL FTEDTFFLEL IQRQGATGFG QGNIRALWQS
   361  VQEQSARSQE A

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against HPDL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.24
Highest tissue expression
4 nTPM

Expression across tissuesHPA

Tissue

  • cerebellum: 4 nTPM
  • colon: 3.4 nTPM
  • stomach: 3.1 nTPM
  • basal ganglia: 2.6 nTPM
  • rectum: 2.5 nTPM
  • small intestine: 2.3 nTPM

Single-cell type

  • cytotrophoblasts: 42 nCPM
  • migrating cytotrophoblasts: 34 nCPM
  • gastric progenitor cells: 23 nCPM
  • enteric stem cells: 19 nCPM
  • enteric transient amplifying cells: 15 nCPM
  • megakaryocyte progenitors: 13 nCPM

Immune cell

  • memory B-cell: 0.6 nTPM
  • NK-cell: 0.4 nTPM
  • MAIT T-cell: 0.3 nTPM
  • memory CD8 T-cell: 0.2 nTPM
  • myeloid DC: 0.2 nTPM
  • naive CD4 T-cell: 0.2 nTPM

Brain region

  • cerebellum: 7.8 nTPM
  • medulla oblongata: 4 nTPM
  • pons: 4 nTPM
  • basal ganglia: 3.9 nTPM
  • thalamus: 3.9 nTPM
  • midbrain: 3.8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about HPDL.

Disease | AllUniProt

Conditions HPDL is implicated in, by any mechanism.

Disease | GeneticClinVar

48 pathogenic / likely-pathogenic of 125 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.43
gnomAD pLI
0
gnomAD missense Z
0.93
DepMap mean gene effect
-0.07
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads HPDL as an antibody target. Whether an autoantibody or antibody against HPDL could matter depends on whether native HPDL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

HPDL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label HPDL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/HPDL. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...